Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Detection Methods in Athletes
NCT06393634Phase 1Completed
- Sponsor
- Sports Medicine Research and Testing Laboratory
- Start
- Nov 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Testosterone TEPI patch in Hypogonadism (2 arms), sponsored by Sports Medicine Research and Testing Laboratory. Primary endpoints: Detection windows of testosterone administered via injection, oral and skin cream at 12 weeks, Changes in serum concentration of testosterone at 12 weeks and 2 more. Started Nov 2024; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT06393634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06393634.